SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
Martin HENTEMANN,Jill WOOD,William SCOTT,Martin MICHELS,Ann-Marie CAMPBELL,Ann BULLION,Ronald ROWLEY,Aniko REDMAN
申请号：
US13908566
公开号：
US20130261113A1
申请日:
2013.06.03
申请国别(地区):
US
年份:
2013
代理人:
摘要：
This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.
